KOPS - Das Institutionelle Repositorium der Universität Konstanz

Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants

Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:4108db6288d46c85adf4441fdf64c0a1

KRUG, Anne K., Nina V. BALMER, Florian MATT, Felix SCHÖNENBERGER, Dorit MERHOF, Marcel LEIST, 2013. Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. In: Archives of Toxicology. 87(12), pp. 2215-2231. ISSN 0340-5761. eISSN 1432-0738. Available under: doi: 10.1007/s00204-013-1072-y

@article{Krug2013-12Evalu-26535, title={Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants}, year={2013}, doi={10.1007/s00204-013-1072-y}, number={12}, volume={87}, issn={0340-5761}, journal={Archives of Toxicology}, pages={2215--2231}, author={Krug, Anne K. and Balmer, Nina V. and Matt, Florian and Schönenberger, Felix and Merhof, Dorit and Leist, Marcel} }

Balmer, Nina V. Matt, Florian Merhof, Dorit eng 2014-02-24T13:02:26Z Matt, Florian Organ-specific in vitro toxicity assays are often highly sensitive, but they lack specificity. We evaluated here examples of assay features that can affect test specificity, and some general procedures are suggested on how positive hits in complex biological assays may be defined. Differentiating human LUHMES cells were used as potential model for developmental neurotoxicity testing. Forty candidate toxicants were screened, and several hits were obtained and confirmed. Although the cells had a definitive neuronal phenotype, the use of a general cell death endpoint in these cultures did not allow specific identification of neurotoxicants. As alternative approach, neurite growth was measured as an organ-specific functional endpoint. We found that neurite extension of developing LUHMES was specifically inhibited by diverse compounds such as colchicine, vincristine, narciclasine, rotenone, cycloheximide, or diquat. These compounds reduced neurite growth at concentrations that did not compromise cell viability, and neurite growth was affected more potently than the integrity of developed neurites of mature neurons. A ratio of the EC50 values of neurite growth inhibition and cell death of >4 provided a robust classifier for compounds associated with a developmental neurotoxic hazard. Screening of unspecific toxicants in the test system always yielded ratios <4. The assay identified also compounds that accelerated neurite growth, such as the rho kinase pathway modifiers blebbistatin or thiazovivin. The negative effects of colchicine or rotenone were completely inhibited by a rho kinase inhibitor. In summary, we suggest that assays using functional endpoints (neurite growth) can specifically identify and characterize (developmental) neurotoxicants. Archives of Toxicology ; 87 (2013), 12. - S. 2215-2231 Leist, Marcel Balmer, Nina V. Schönenberger, Felix Merhof, Dorit 2013-12 Schönenberger, Felix Leist, Marcel 2014-02-24T13:02:26Z Krug, Anne K. deposit-license Krug, Anne K. Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Krug_265359.pdf 316

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto